下一代定序 (NGS) 測試市場:管道報告2023 年最新版
市場調查報告書
商品編碼
1405138

下一代定序 (NGS) 測試市場:管道報告2023 年最新版

Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: | 出版商: GlobalData | 英文 285 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

下一代定序(NGS)是指非桑格DNA定序的高通量方法。NGS技術在學術和基因組研究中已經取代了桑格測序,並越來越多地應用於臨床實踐。

該報告調查了下一代定序(NGS)測試市場,提供了產品概述、正在開發的管道產品的趨勢、處於不同開發階段的產品的比較分析、正在進行的臨床試驗的資訊以及參與公司的資訊。最近的趨勢等

目錄

第一章 內容

第 2 章 簡介

第三章 開發中產品

  • 下一代定序 (NGS) 測試 - 按開發階段劃分的管道產品
  • 下一代定序 (NGS) 測試 - 按地區劃分的管道產品
  • 下一代定序 (NGS) 測試 - 按監管途徑分類的管道產品
  • 下一代定序 (NGS) 試驗 - 按預計批准日期排列的管道產品
  • 下一代定序 (NGS) 試驗 - 正在進行的臨床試驗

第 4 章 下一代定序 (NGS) 測試 - 公司正在開發的管道產品

  • 下一代定序 (NGS) 測試公司 - 按開發階段劃分的管道產品
  • 下一代定序 (NGS) 測試 - 按開發階段劃分的管道產品

第五章 新一代定序(NGS)檢測企業及產品概述

第 6 章 下一代定序 (NGS) 測試 - 最新進展

第7章附錄

Abstract

GlobalData's Medical Devices sector report, "Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Next Generation Sequencing (NGS) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Next generation sequencing (NGS) refers to high-throughput methods for DNA sequencing that are not Sanger-based. NGS technology has largely superseded Sanger sequencing in academic or genome research and is increasingly being applied in clinical practice.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Next Generation Sequencing (NGS) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Next Generation Sequencing (NGS) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Next Generation Sequencing (NGS) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Next Generation Sequencing (NGS) Tests Overview

3 Products under Development

  • 3.1 Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
  • 3.2 Next Generation Sequencing (NGS) Tests - Pipeline Products by Territory
  • 3.3 Next Generation Sequencing (NGS) Tests - Pipeline Products by Regulatory Path
  • 3.4 Next Generation Sequencing (NGS) Tests - Pipeline Products by Estimated Approval Date
  • 3.5 Next Generation Sequencing (NGS) Tests - Ongoing Clinical Trials

4 Next Generation Sequencing (NGS) Tests - Pipeline Products under Development by Companies

  • 4.1 Next Generation Sequencing (NGS) Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development

5 Next Generation Sequencing (NGS) Tests Companies and Product Overview

6 Next Generation Sequencing (NGS) Tests- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Territory
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Regulatory Path
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Estimated Approval Date
  • Next Generation Sequencing (NGS) Tests - Ongoing Clinical Trials
  • Next Generation Sequencing (NGS) Tests Companies - Pipeline Products by Stage of Development
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Stage of Development
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Territory
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Regulatory Path
  • Next Generation Sequencing (NGS) Tests - Pipeline Products by Estimated Approval Date
  • Next Generation Sequencing (NGS) Tests - Ongoing Clinical Trials